Biokarpet S.A. (ATH:BIOKA)

Biokarpet Statistics

Total Valuation

Biokarpet has a market cap or net worth of EUR 46.41 million. The enterprise value is 144.37 million.

Market Cap	46.41M
Enterprise Value	144.37M

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	Aug 25, 2025

Share Statistics

Biokarpet has 23.99 million shares outstanding. The number of shares has decreased by -2.02% in one year.

Current Share Class	23.99M
Shares Outstanding	23.99M
Shares Change (YoY)	-2.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.01%
Owned by Institutions (%)	10.48%
Float	14.39M

Valuation Ratios

The trailing PE ratio is 24.08.

PE Ratio	24.08
Forward PE	n/a
PS Ratio	0.22
PB Ratio	0.93
P/TBV Ratio	0.95
P/FCF Ratio	14.97
P/OCF Ratio	2.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.97, with an EV/FCF ratio of 46.57.

EV / Earnings	76.45
EV / Sales	0.69
EV / EBITDA	10.97
EV / EBIT	23.74
EV / FCF	46.57

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 2.31.

Current Ratio	1.69
Quick Ratio	1.12
Debt / Equity	2.31
Debt / EBITDA	8.72
Debt / FCF	37.05
Interest Coverage	0.91

Financial Efficiency

Return on equity (ROE) is 3.85% and return on invested capital (ROIC) is 2.35%.

Return on Equity (ROE)	3.85%
Return on Assets (ROA)	1.75%
Return on Invested Capital (ROIC)	2.35%
Return on Capital Employed (ROCE)	3.91%
Revenue Per Employee	321,594
Profits Per Employee	2,883
Employee Count	655
Asset Turnover	0.97
Inventory Turnover	4.70

Taxes

In the past 12 months, Biokarpet has paid 456,898 in taxes.

Income Tax	456,898
Effective Tax Rate	19.31%

Stock Price Statistics

The stock price has increased by +11.85% in the last 52 weeks. The beta is 0.44, so Biokarpet's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+11.85%
50-Day Moving Average	1.91
200-Day Moving Average	1.81
Relative Strength Index (RSI)	57.54
Average Volume (20 Days)	34,508

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biokarpet had revenue of EUR 210.64 million and earned 1.89 million in profits. Earnings per share was 0.08.

Revenue	210.64M
Gross Profit	32.57M
Operating Income	6.08M
Pretax Income	2.37M
Net Income	1.89M
EBITDA	11.70M
EBIT	6.08M
Earnings Per Share (EPS)	0.08

Balance Sheet

The company has 17.70 million in cash and 114.83 million in debt, giving a net cash position of -97.13 million or -4.05 per share.

Cash & Cash Equivalents	17.70M
Total Debt	114.83M
Net Cash	-97.13M
Net Cash Per Share	-4.05
Equity (Book Value)	49.81M
Book Value Per Share	2.13
Working Capital	47.37M

Cash Flow

In the last 12 months, operating cash flow was 17.50 million and capital expenditures -14.40 million, giving a free cash flow of 3.10 million.

Operating Cash Flow	17.50M
Capital Expenditures	-14.40M
Free Cash Flow	3.10M
FCF Per Share	0.13

Margins

Gross margin is 15.46%, with operating and profit margins of 2.89% and 0.90%.

Gross Margin	15.46%
Operating Margin	2.89%
Pretax Margin	1.12%
Profit Margin	0.90%
EBITDA Margin	5.56%
EBIT Margin	2.89%
FCF Margin	1.47%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.05%.

Dividend Per Share	0.02
Dividend Yield	1.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	2.02%
Shareholder Yield	3.07%
Earnings Yield	4.07%
FCF Yield	6.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 15, 2000. It was a forward split with a ratio of 2.

Last Split Date	Mar 15, 2000
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	5